Davide Campari-Milano NV (MIL:CPR) Beta: 0.3501 (As of Jun. 25, 2026)


MIL:CPR Davide Campari-Milano NV MIL:CPR
77 GF Score
Price €5.48
GF Value €7.88
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Davide Campari-Milano NV Beta?

Davide Campari-Milano NV MIL:CPR +1.07% 77 Beta is 0.3501 as of Jun. 25, 2026. GuruFocus rates MIL:CPR with a GF Score™ of 77/100 and a GF Value™ of €7.88 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Davide Campari-Milano NV's Beta is 0.3501.


Davide Campari-Milano NV  (MIL:CPR) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Davide Campari-Milano NV Beta Related Terms


Davide Campari-Milano NV Beta Historical Data

* Premium members only.

The historical data trend for Davide Campari-Milano NV's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Davide Campari-Milano NV Beta Chart

Davide Campari-Milano NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.49 0.39 0.06 0.14

Davide Campari-Milano NV Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.34 0.45 0.37 0.14

MIL:CPR vs BF.B: Beta Comparison

For the Beverages - Wineries & Distilleries subindustry, Davide Campari-Milano NV's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Davide Campari-Milano NV Beta vs Beverages - Alcoholic Industry

For the Beverages - Alcoholic industry and Consumer Defensive sector, Davide Campari-Milano NV's Beta distribution charts can be found below:

* The bar in red indicates where Davide Campari-Milano NV's Beta falls into.


MIL:CPR
77GF Score
Davide Campari-Milano NV MIL:CPR
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Davide Campari-Milano NV Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3501 mean?
Davide Campari-Milano NV (MIL:CPR) has a Beta of 0.3501 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Davide Campari-Milano NV and its competitors.
Is Davide Campari-Milano NV's Beta too high?
Davide Campari-Milano NV's current Beta is 0.3501. Overall, Davide Campari-Milano NV has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Davide Campari-Milano NV's Beta compare to BF.B?
Davide Campari-Milano NV's Beta of 0.3501 can be compared against companies in the Beverages - Alcoholic industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Beverages - Alcoholic company?
A good Beta depends on the Beverages - Alcoholic industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Davide Campari-Milano NV and its competitors. Davide Campari-Milano NV's current Beta is 0.3501. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Davide Campari-Milano NV stock overvalued right now?
Based on GuruFocus' analysis, Davide Campari-Milano NV (MIL:CPR) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.88, compared to a current price of €5.48 — trading 30.4% below its estimated fair value. The current Beta is 0.3501. Davide Campari-Milano NV's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Davide Campari-Milano NV (MIL:CPR), the current Beta is 0.3501 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Davide Campari-Milano NV (MIL:CPR) Overvalued in 2026?

Based on GuruFocus' analysis, Davide Campari-Milano NV stock appears to be undervalued. The current stock price of €5.48 is trading 30.4% below its estimated GF Value™ of €7.88. GuruFocus considers Davide Campari-Milano NV to be Significantly Undervalued.

Key valuation signals for MIL:CPR:

  • Beta: 0.3501
  • GF Value™: €7.88 vs. price of €5.48 (30.4% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the MIL:CPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Davide Campari-Milano NV Business Description

Address Via Franco Sacchetti 20, Sesto San Giovanni, Milan, ITA, 20099
Davide Campari-Milano is the Italian-headquartered parent of Campari Group and is the world's leading manufacturer of bitters, with a volume share of around 24% in 2025, according to Euromonitor. The company's liqueur portfolio includes Aperol, Campari, and Grand Marnier. The remainder of the portfolio spans a wide range of categories, including global brands Skyy vodka and Wild Turkey bourbon and niche brands such as Appleton Estate rum, Bulldog gin, and Espolòn tequila. Campari also produces and markets a range of Champagne and sparkling wines. Campari is controlled by Lagfin, a Luxembourg-based holding company, which holds 52% of the share capital and over 60% of the voting rights. The rest of the equity is free floating.
77GF Score

Get the complete analysis for MIL:CPR

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.48
Price
€7.88
GF Value